New Year Bumper Sale @ Rs. 1 X
CA 007 250/1000 Injection 10 Ml is a prescription drug, available for use as Injection. Other than this, CA 007 250/1000 Injection 10 Ml has some other therapeutic uses, which have been discussed ahead.
The right dosage of CA 007 250/1000 Injection 10 Ml depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, CA 007 250/1000 Injection 10 Ml can also lead to other problems, which have been listed below. Usually, these side effects of CA 007 250/1000 Injection 10 Ml go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
CA 007 250/1000 Injection 10 Ml's effect during pregnancy is Safe and Mild while nursing. It is important to know if CA 007 250/1000 Injection 10 Ml has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the CA 007 250/1000 Injection 10 Ml related warnings section.
Individuals suffering from medical conditions like Dehydration, Parkinson's Disease, Hearing Loss must refrain from the use of CA 007 250/1000 Injection 10 Ml since this can cause severe adverse effects. Other contraindications of CA 007 250/1000 Injection 10 Ml have been discussed in the sections ahead.
Drug reaction of CA 007 250/1000 Injection 10 Ml with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that CA 007 250/1000 Injection 10 Ml is not safe while driving, and is is not addictive in nature.
CA 007 250/1000 Injection 10 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when CA 007 250/1000 Injection 10 Ml is used -
Moderate
Mild
Unknown
Is the use of CA 007 250/1000 Injection 10 Ml safe for pregnant women?
Pregnant women can take CA 007 without worrying about any side effects.
Is the use of CA 007 250/1000 Injection 10 Ml safe during breastfeeding?
Side effects of CA 007 for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of CA 007 250/1000 Injection 10 Ml on the Kidneys?
CA 007 rarely affects the kidneys.
What is the effect of CA 007 250/1000 Injection 10 Ml on the Liver?
Using CA 007 does not have any harmful effects on the liver.
What is the effect of CA 007 250/1000 Injection 10 Ml on the Heart?
Using CA 007 does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take CA 007 250/1000 Injection 10 Ml unless your doctor advises you to do so -
Is this CA 007 250/1000 Injection 10 Ml habit forming or addictive?
No, you will not get addicted to CA 007 250/1000 Injection 10 Ml.
Interaction between Food and CA 007 250/1000 Injection 10 Ml
Taking CA 007 250/1000 Injection 10 Ml with food does not harm your health.
Interaction between Alcohol and CA 007 250/1000 Injection 10 Ml
It is difficult to say anything about the effect of CA 007 250/1000 Injection 10 Ml and alcohol. No research has been done on this yet.
Discontinuing CA 007 on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
No, CA 007 does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Yes, CA 007 is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if CA 007 taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking CA 007 with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
Yes, CA 007 can be taken with lidocaine. The clinical report suggests that no harmful drug-drug interactions have been observed between them so far. However, it doesn't mean that no interaction could exist between them. These two medicines are high alert drug so you must consult your doctor before taking CA 007 together.
Do not self-administer CA 007. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking CA 007 please inform your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)